[PLX] QoQ Quarter Result on 31-Dec-2019 [#Q4]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
12-Mar-2020
Financial Year
2019
Quarter
31-Dec-2019 [#Q4]
Profit Trend
QoQ- 108.17%
YoY- -97.02%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Revenue 10,790 10,967 21,646 17,759 14,248 12,247 10,439 2.22%
PBT -4,437 -4,150 1,667 291 -3,560 -7,743 -7,264 -27.94%
Tax 118 38 203 180 34 3 190 -27.14%
NP -4,437 -4,150 1,667 291 -3,560 -7,743 -7,264 -27.94%
Tax Rate - - -12.18% -61.86% - - - -
Total Cost 15,227 15,117 19,979 17,468 17,808 19,990 17,703 -9.53%
Ratio Analysis
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
NP Margin -41.12 -37.84 7.70 1.64 -24.99 -63.22 -69.59 -29.51%
Per Share
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
EPS -0.14 -0.13 0.10 0.02 -0.24 -0.52 -0.49 -56.52%
EPS Diluted -0.14 -0.13 0.10 0.02 -0.24 -0.52 -0.49 -56.52%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.